Chemical cleavage of the VP6 protein of bovine rotavirus showed that VP6-specific monoclonal antibodies (MAbs) reacted with the amino acid sequence between glycine 48 and asparagine 107. Furthermore, three synthetic peptides (amino acids 48 to 64, 60 to 75 and 91 to 108) containing part of this sequence and 22 consecutive overlapping heptapeptides corresponding to the region between amino acids 48 and 75 were analysed for their immunoreactivity using groupspecific MAbs. The MAbs recognized peptides 48-64 and/or 60-75, and a set of overlapping heptapeptides located between residues 53 (asparagine) and 67 (glycine), which have two short sequences in common: IRNW (residues 56 to 59), recognized by MAb RV-133, and (NW)NFD (residues 58/60 to 62), recognized by MAbs RV-50, -1026 and -443. These results indicate that the sequence between amino acid residues 48 and 75 is present in one of the immunodominant sites of VP6.
Introduction
The members of the rotavirus genus of the Reoviridae family are a major cause of acute gastroenteritis in young children. Rotaviruses consist of two icosahedral protein shells surrounding a core, which is composed of three polypeptides, VP1 (125K), VP2 (102K) and VP3 (88K) (Bican et al., 1982; Liu et al., 1988) , and contains the 11 dsRNA genome segments. The outer shell of the virus contains two proteins, designated VP7 (37K) and VP4 (87K), which play a role in cell attachment and penetration (Fukuhara et al., 1988; Mackow et al., 1988) . The major component of the inner capsid, VP6 (45K), surrounds the core and corresponds to the morphological subunit responsible for the rough outline of single-shelled particles (Novo & Esparza, 1981) . Several studies have shown that VP6 is present as a trimer on single-shelled particles and in infected cells (Gorziglia et al., 1985; Sabara et al., 1987; Prasad et al., 1988) . The domains that are essential for trimerization and assembly into singleshelled particles have recently been located near the centre (between amino acids 105 and 328) and at the C-terminal of VP6 (between amino acids 251 and 397), respectively (Clapp & Patton, 1991) . VP6 has been associated with viral RNA transcriptase activity, and although it has no polymerase activity itself, removal of VP6 from single-shelled particles with chaotropic agents yields core particles that are transcriptionally inactive (Bican et al., 1982; Sandino et al., 1986) . The transcriptase activity is restored by the reconstitution of the core with purified VP6.
VP6 is highly immunogenic and is the major polypeptide immunoprecipitated by convalescent patients' sera or sera from vaccines (Svensson et al., 1987a, b) . The protein is detected in a variety of diagnostic assays and contains both subgroup-and common group-specific epitopes; the latter could be continuous determinants and one of them has been shown to be located in the first 80 amino acids (Gorziglia et al., 1988) . Whether VP6 plays a role in inducing protection against infection remains unclear. A synthetic peptide corresponding to amino acids 40 to 60 of VP6 has been reported to induce protective immunity in mice , but the neutralizing antibodies produced are directed mostly against the outer capsid antigens (VP4 and VP7) (Matsui et al., 1989) .
We have previously studied the antigenic organization of VP6 of the bovine rotavirus RF strain by using groupspecific monoclonal antibodies (MAbs) to VP6 in a competitive binding assay (Pothier et al., 1987) . Three antigenic domains involved in group specificity were defined on VP6: site I (MAbs RV-50 and RV-1026), site II (MAb RV-443) and site III (MAb RV-133); a fourth site not involved in group specificity is recognized by MAb RV-138. Nevertheless, further competitive binding assays performed with virus in solution indicated a 0001-0683 © 1992 SGM unidirectional competition between MAbs RV-50 or  RV-1026 and MAb RV-443, and between MAbs RV-133  and RV-138 (unpublished results) . This unidirectional competition suggested that sites I and II, and III and IV, are in physical proximity or that they partially overlap.
To define the location of these group-specific epitopes further, we tested the reactivity of our MAbs with fragments of VP6 obtained by chemical cleavage and with synthetic peptides. The results indicated that the region between amino acids 48 and 75 is detected by these four group-specific MAbs.
Methods
Cells and virus. The RF strain of bovine rotavirus (subgroup 1) was propagated in African green monkey kidney cells (MA 104) and partially purified by centrifugation at 90000 g for 2 h through a 40% (w/v) sucrose cushion in Tris-HCl pH 8.
MAbs andpolyclonal sera. Production, characterization and biotinylation of MAbs have been described previously (Pothier et al., 1987) . Rabbit anti-rotavirus antiserum was obtained by injection of complete particles, purified by ultracentrifugation in a caesium chloride gradient.
Chemical cleavage of VP6. Viral proteins were first subjected to 11% SDS-PAGE under denaturing conditions using the discontinuous system (Laemmli, I970) . The gels were stained briefly with Coomassie blue, and the bands containing VP6 cut out with a razor blade and transferred to vials containing fragmentation mixture.
Two chemical agents were used: hydroxylamine (NH2OH), which cleaves asparagine-glycine bonds, and N-cblorosuccinimide (NCS), which cleaves at tryptophan residues. For cleavage, gel slices containing VP6 were incubated with the chemical agent according to the following procedures. For cleavage with NHzOH , gel slices were incubated for 3 h at 45 °C in a cleavage mixture containing 2 ihydroxylamine hydrochloride (Sigma), 15 mi-Tris base and 4.5 Mlithium hydroxide (Merck) (Saris et al., 1983) . For cleavage with NCS, gel slices were incubated for 30 min at room temperature with 15 mM-NCS (Sigma) with l g urea, 1 ml H20 and 1 ml acetic acid (Lischwe & Ochs, 1982) .
After incubation, gel slices containing cleaved VP6 were washed and equilibrated in 10% glycerol, 2% 2-mercaptoethanol, 3% SDS in 625 mi-Tris-HC1 pH 6.8 before loading onto a second SDSpolyacrylamide gel (15%). The peptide fragments were then either silver-stained using the Bio-Rad silver stain kit or immunoblotted. Fragments were put into order by comparing the Mr of observed fragments and the Mr of the theoretical fragments deduced from the amino acid sequence of VP6 .
Immunoblotting. Peptide fragments, resulting from the cleavage of VP6 and separated by SDS-PAGE, were blotted onto nitrocellulose sheets (0-10 ~tm, Schleicher & Schuell) in a transfer buffer consisting of 25 mi-Tris-HCl pH 8.3, 190 mM-glycine, 20% methanol. Transfer was carried out at 0.6 V/cm 2 for 1 h. Non-specific adsorption sites on nitrocellulose were saturated by incubation for 1 h at 37 °C in PBS containing 5% (w/v) BSA. The nitrocellulose strips were then washed in PBS, 1% (w/v) BSA, 0.2% (v/v) Tween 20 (PBT buffer) and incubated under mild agitation for 1 h at 37°C with 10 ml of appropriately diluted ascitic fluid or culture supernatant. The nitrocellulose strips were then washed three times in PBT buffer and further incubated for 1 h at 37 °C with a 1 : 2000 dilution of peroxidaseconjugated goat anti-mouse IgG antiserum (Bio-Rad). Specific immunoblotted bands were visualized using 0.05% (w/v) 3,Y-diaminohenzidine tetrahydrochloride (Sigma) in Tris-HC1 pH 7-6 containing 0.25 % (v/v) H202 . The reaction was stopped with 0.5 M-HESO4 and the strips were washed in distilled water.
Syntheticpeptides. Three peptides (amino acids 48 to 64, 60 to 75 and 91 to 108) from within the region between residues 42 and 107 were chosen from the results of VP6 cleavage and the epitopes predicted using the computer program Macro-Biosoft (Prolabo). The peptides were synthesized by a solid-phase method on a Biolynx 4175 peptide synthesizer (Pharmacia) using N~-(9-fluorenylmethoxycarbonyl)-protected amino acids (Atherton & Sheppard, 1985) and a polyamide solid phase as described previously (Bourgeois et al., 1991) . A sample of the crude peptide was then hydrolysed for amino acid and HPLC analysis.
In addition, 22 consecutive overlapping heptapeptides corresponding to the region between amino acids 48 and 75 were synthesized on polyethylene rods using a commercially available kit (Epitope scanning; Cambridge Research Biochemicals). The first peptide consisted of amino acids 48 to 54, the last of residues 69 to 75. The reactivity of the peptides with the MAbs in culture supernatant (dilution 1:20) or ascitic fluid (dilution 1:10a), and with rabbit antirotavirus antiserum (dilution 1:104) was determined in an ELISA (Geysen et al., 1984) .
Coupling of peptides to carrier protein and preparation of antisera.
Peptides 48-64 and 60-75 were coupled to BSA through their carboxyl group using 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (Sigma). The conjugates were dialysed overnight against PBS.
Female mice (BALB/c strain) of approximately 6 weeks of age were immunized intraperitoneally with either 50 ~tg of peptide or 50 ~tg of peptide-BSA conjugate. Complete Freund's adjuvant was used for the first injection and incomplete Freund's adjuvant for the following two or three injections given at biweekly intervals. Blood was collected before the first and the second injections, and 14 days after the third. Binding of anti-peptide antibodies to the relevant peptides or the whole virus was determined by ELISA.
ELISA techniques. The wells of microtitre plates were coated overnight at 37 °C with either partially purified virus (1 p.g/well on regular 96-well ELISA plates) or free peptides [2 ixg/well using the Covalink system (Nunc)] in 0.1 M-carbonate coating buffer pH 9.6. Binding sites in the wells were saturated by incubation with 2% non-fat milk for 1 h at 37 °C. For the different assays, incubation times were 1 h at 37 °C after each addition of 100 ~tl of reagent per well, followed by washing with PBS pH 7-2 containing 0.05% Tween 20. The diluent throughout was PBS, 1% BSA, 0.05 % Tween 20, and antisera prepared against conjugated peptides were first adsorbed in 5% (w/v) BSA in PBS pH 7.2. The binding of antibodies to peptides or the whole virus was assessed by direct ELISA and competitive ELISA respectively.
(i) Direct ELISA. MAbs and anti-rotavirus or anti-peptide sera were incubated on wells coated with peptides or the whole virus. Two control values were established to assess the background by using an irrelevant MAb and a well without antigen. Binding of antibodies was revealed by addition of peroxidase-labelled goat anti-mouse IgG or anti-rabbit Ig. After addition of peroxidase substrate, the absorbance was measured on a Titertek Multiskan spectrophotometer at 492 nm. Titres of antipeptide sera were expressed as the serum dilution giving an absorbance value greater than that of the control plus 0.100.
(ii) Competitive ELISA. Several dilutions of competitor antigen (whole virus or peptide) were preincubated for 1 h at 37 °C with equal volumes of constant, predetermined dilutions of MAbs in siliconecoated vials. Samples of each mixture were transferred to duplicate wells coated with whole virus and incubated for 1 h at 37 °C. After washing, peroxidase-labelled goat anti-mouse IgG was added as described above. The level of competition was calculated as a percentage using the formula 100(A -B)/A, where A is the absorbance in the absence of virus or relevant peptide in the solution and B is the absorbance in the presence of virus or relevant peptide in the solution.
The background values described previously were subtracted before calculation of A and B.
Results

Immunoreactivity of fragments resulting from chemical cleavage of VP6
Some VP6 fragments resulting from chemical cleavage with NH2OH and NCS were immunostained with MAbs.
NH2OH cleaves asparagine-glycine bonds and should in theory produce peptides containing amino acids 1 to 42, 43 to 107, 108 to 266 and 267 to 397. The VP6 fragments resulting from this digestion were stained after electrophoresis and compared to the size markers. Five fragments were obtained of Mr 4"6K (residues 1 to 42), 7.4K (residues 43 to 107), 12.8K (residues 1 to 107), 15-4K (residues 267 to 397) and 18-2K (residues 108 to 266). In addition we observed larger intermediate fragments resulting from incomplete cleavage. All MAbs tested [RV-50, RV-1026 (site I), RV-443 (site II), RV-133 (site III) and RV-138 (site IV)] recognized the 12-8K fragment, which we interpreted as containing amino acids 1 to 107 of the VP6 protein produced by incomplete cleavage of the bond between amino acids 42 and 43 (Fig. 1 a) . MAbs RV-1026 and RV-443 reacted with the smaller 7.4K fragment (Fig. l b) . These conflicting results could be explained by variation in the level of cleavage and by differences in the quantity of VP6 in gel slices.
NCS cleaves at tryptophan residues 59, 139, 181,247 and 367 of the VP6 protein. For this reagent it was very difficult to assign the experimentally obtained fragments to theoretical fragments, so it was not possible to locate epitopes according to the immunoreactivity of the fragments with MAbs. Nevertheless, we observed that MAbs RV-50, RV-133 and RV-138 gave the same pattern of reactivity, whereas MAbs RV-1026 and RV-443 (Fig. 2) did not recognize any fragment. This latter result strongly suggests that tryptophan 59 is part of the epitope for MAbs RV-1026 and RV-443, or that the conformation of these epitopes is altered by cleavage.
The results obtained with NCS and NHzOH suggested that the five MAbs recognize the N-terminal region of the VP6 protein (amino acids 1 to 107), and that MAbs RV-1026 and RV-443, specific for sites I and II, bind more precisely to the region located between amino acids 43 and 107. After considering hydrophobicity, flexibility, occurrences of fl-turns and secondary structure (Gamier et al., 1978; Hopp & Woods, 1981; J anin, 1979; Karplus & Schulz, 1985) , we synthesized three peptides contain- 
in order to localize the antigenic sites more precisely.
Immunogenicity of the synthetic peptides
The peptides 48-64 and 60-75 were used either coupled to BSA or free to raise anti-peptide antibodies in mice. For these peptides, both forms (coupled or uncoupled) were able to elicit antibodies which bound to the relevant free peptide and to the whole virus adsorbed onto microtitre plates in a direct ELISA. The mean peak antibody titres for the antisera obtained from four mice are presented in Table 1 . Peptide 91-108, which did not react with any of the MAbs (see below), was not included in the study of immunogenicity.
Reactivity in a direct ELISA of rabbit anti-rotavirus serum and MAbs with synthetic VP6 peptides
Recognition of the three synthetic peptides by rabbit anti-rotavirus serum and by MAbs recognizing each of the antigenic sites was first investigated in a direct ELISA ( Table 2 ). The rabbit anti-rotavirus serum and MAbs RV-50 and RV-1026 (site I) reacted with peptide 48-64 and more weakly with peptide 60-75; MAb RV-133 (site l i d reacted only with peptide 48-64. Peptide 91-108 was not recognized by any of these MAbs, as has been found by others with rabbit antirotavirus serum (Borras-Cuesta et al., 1987) ; MAbs RV-443 (site II) and RV-138 (site IV) did not react with these peptides. No reaction was observed with an irrelevant peptide used as a negative control.
Inhibition studies
Serial dilutions of peptides were used as competitor antigen to inhibit the binding of antibodies to captured virus particles. Competitive binding curves are shown in Fig. 3 (a to c) and the concentration of competitor when inhibition was 5 0~ are presented in 
• [ k L L 51 52 53 54 55 5E 62 63 64 65 67 68 69 There was no competition in negative control experiments (data not shown).
Epitope scanning
To locate the MAb binding sites more accurately, 22 overlapping heptapeptides corresponding to the region between amino acids 48 and 75 were synthesized by the epitope scanning procedure and tested for binding with MAbs RV-50, -133, -138, -443 and -1026. Reactivity was scored as positive for absorbance values greater than 0-2 absorbance units. MAbs RV-1026 and -50 (antigenic site I) recognized four and five consecutive heptapeptides, respectively (Fig. 4) . MAb RV-1026 recognized the heptapeptides from residue 56 (isoleucine) to residue 65 (leucine), and MAb RV-50 recognized the heptapeptides from residue 56 (isoleucine) to residue 66 (leucine). These peptides have the sequence NFD (residues 60 to 62) in common. However, both MAbs strongly recognized the heptapeptides IRNWNFD, RNWNFDF and NWNFDFG, the stretch NWNFD being critical for antibody recognition (Fig. 4) .
MAb RV-443 (antigenic site II) recognized only the heptapeptide NWNFDFG (residues 58 to 64), including the sequence recognized by both site I-specific MAbs (Fig. 4) .
MAb RV-133 recognized four heptapeptides, at the amino end of the previous sequence, from residue 53 (asparagine) to residue 61 (phenylalanine). These heptapeptides shared the sequence IRNW (residues 56 to 59). In addition, MAb RV-133 recognized another heptapeptide corresponding to the sequence LLGTTLL (residues 65 to 70), located in the C-terminal region of the region studied. MAb RV-138 did not react significantly with any of these peptides (data not shown).
Discussion
The different methods (chemical cleavage, synthetic peptides and epitope scanning) allowed us to define an antigenic and immunogenic region of rotavirus VP6 located between residues 48 (threonine) and 75 (alanine). Two synthetic peptides corresponding to this region, peptides 48-64 and/or 60-75, were recognized by groupspecific MAbs and by a rabbit anti-rotavirus serum. VP6-specific MAbs recognized overlapping heptapeptides located between residues 53 (asparagine) and 66 (leucine). The pattern of reactivity for each MAb showed two short sequences, IRNW (residues 56 to 59) and (NW)NFD (residues 58/60 to 62), common to the heptapeptides recognized by MAb RV-133, and by MAbs RV-50, -1026 and -443. MAb RV-133 also weakly recognized a heptapeptide between residues 65 (leucine) and 71 (leucine), which may account for the moderate reactivity of MAb RV-133 with peptide 60-75 in the inhibition studies. The epitopes recognized by MAbs RV-50, -1026 and -443 contain a tryptophan (residue 59). After chemical cleavage of VP6 with NCS, MAbs RV-1026 and -443 did not recognize any fragment, whereas the binding site of MAb RV-50 was not affected. This suggests that this tryptophan residue is not essential for the binding of this MAb under these particular conditions. This hypothesis was also supported by the reactivity of MAb RV-50 with two heptapeptides located after tryptophan 59 in the epitope scanning procedure.
Some discrepancies were observed between these results and those obtained with the procedures used to characterize the antigenic sites on VP6 (Pothier et al., 1987) . MAbs RV-50 and -1026 (antigenic site I), and MAb RV-443 (antigenic site II) recognized the same peptide NWNFDFG in the epitope scanning procedure. Nevertheless, topological mapping of the virus in solution showed unidirectional competition between these MAbs. The binding of MAbs RV-50 or -1026 inhibited the binding of MAb RV-443, but binding of MAb RV-443 did not inhibit the binding of MAb RV-50 or -1026. This unidirectional competition may be due to partial overlap, the common sequence not being the complete epitope of MAbs RV-50 and -1026, another sequence being located in another part of VP6.
The heptapeptide recognized by MAb RV-443 has a part in common with peptides 48-64 and 60-75, but this MAb only recognized the soluble form of peptide 60-75. Conversely, MAbs RV-50 and RV-1026, recognizing the same region in the epitope scanning procedure, were inhibited by both peptides 48-64 and 60-75. These discrepancies could be due to the length, or presentation of the epitopes, or the conformation of the peptides, which is probably different in solution and when linked to a solid phase. Neither procedure can reproduce exactly the natural conditions encountered by the antibody on the virus particle, but they create particular conditions which may modify antibody binding (Spangler, 1991) .
Comparison of the nucleotide sequences of gene 6 of rotavirus strains belonging to different groups and subgroups has revealed some changes in amino acid composition in the region between residues 48 and 75. It is suggested that the isoleucine at position 56 could contribute to subgroup I specificity (Gorziglia et al., 1988) , but the fact that this amino acid is included in the epitope of the group-specific MAb RV-133 suggests that a conservative change at this position (isoleucine to valine) is not critical for subgroup specificity. Comparison of group A and group C VP6 Bremont et al., 1990) amino acid sequences revealed the existence of several changes in the region between residues 53 and 65, although not at amino acids 59, 60 and 61. The conserved sequence at these positions, WNF, is included in the heptapeptides recognized by the group A-specific MAbs RV-50, -1026 and -443, suggesting that amino acids 56 to 58 could play a major role in the specificity of this group epitope. Secondary structure predictions (Garnier et al., 1978) indicate that group A, B (Chen et al., 1991) and C VP6 molecules present a loop between the conserved proline 55 and glycine 64 (Pro 66 and Pro 64 for groups B and C, respectively).
Data presented here are consistent with previous results showing that group-specific MAb 4B5 immunoprecipitates the first 80 amino acids of VP6 (Gorziglia et al., 1988) . Similarly, Frenchick et al. (1987) have identified a region spanning amino acids 40 to 60 which is recognized by anti-VP6 antibodies. Several studies have identified immunodominant regions in other viruses such as foot-and-mouth disease virus (Meloen et al., 1987) , poliovirus (Hogle et al., 1985) , human immunodeficiency virus (Goudsmit et al., 1988; Gnann et al., 1987) and infectious bronchitis virus (Kusters et al., 1989) . Different antigenic structures have been described corresponding either to conformational epitopes, which are not usually reproduced by short synthetic peptides, or sequential continuous or discontinuous epitopes, which are reproduced by short peptides. The reactivity observed showed that the epitopes recognized by our group-specific MAbs are sequential determinants, in contrast to the subgroup epitopes which seem to be conformational (Gorziglia et al., 1988) . However, we cannot rule out the possibility that the MAb (RV-50 and RV-1026) binding site could be the result of the association of two linear stretches of amino acids.
It is known that the major protein of the inner capsid is able to restore the transcriptase activity of cores (Bican et al., 1982; Sandino et al., 1986) , probably by inducing a change in core structure or in the organization of the transcriptional complex. It is likely that the region of VP6 responsible for this activity is conserved in both subgroups. The use of synthetic peptides and groupspecific MAbs could be used to explore this hypothesis.
In conclusion, we have located the binding site of group-specific MAbs to the N-terminal end of the major protein of the inner capsid; the sequences IRNW and (NW)NFD seem to be important to these binding sites.
The group-specific MAbs we have characterized in this study, and the corresponding oligopeptides, could be used to locate functional domains conserved in the various subgroups. They could also be used to block the restoration of endogenous transcriptase activity produced by addition of VP6 to viral cores, as the region of VP6 responsible for this mechanism is likely to be conserved.
